Analyt |
Geschlecht |
Von Alter bis Alter |
Referenzintervall |
Einheit |
(* = nicht spezifiziert), Bemerkung |
T=Tag, M=Monat |
|
J=Jahr |
abgel. Fibrinogen |
* |
|
|
|
|
180-350 |
|
ABO,Iso,D (CDE) |
* |
|
|
|
|
|
|
ABO,Iso,Rh |
* |
|
|
|
|
|
|
ABO,Iso,Rh-Notfall |
* |
|
|
|
|
|
|
Acetessigsäure i.U. |
* |
|
|
|
|
Negativ |
|
Aceton i.Urin |
* |
|
|
|
|
Negativ |
|
AFP |
* |
|
|
|
|
0 – 15 |
ng/ml |
AK gg. Doppelstr.DNS siehe Anti-ds-DNA |
* |
|
|
|
|
Negativ (<1:10) |
|
AK gg. glatte Musk. siehe ASMA |
* |
|
|
|
|
Negativ (<1:80) |
Titer |
AK gg. M2 (Blot) |
* |
|
|
|
|
Negativ |
|
AK gg.Parietalzellen siehe LKM |
* |
|
|
|
|
Negativ (<1:80) |
Titer |
AK gg. Zentromer (Blot) |
* |
|
|
|
|
Negativ |
|
AK-Diff. Coombs |
* |
|
|
|
|
|
|
AK-Diff. Enzym |
* |
|
|
|
|
|
|
AK-Diff. NaCl |
* |
|
|
|
|
|
|
AKS Coombs 2 Zellen |
* |
|
|
|
|
|
|
AKS Enzym 2 Zellen |
* |
|
|
|
|
|
|
AKS NaCl 2 Zellen |
* |
|
|
|
|
|
|
AKS-Notfall |
* |
|
|
|
|
|
|
AKSS-Coombs |
* |
|
|
|
|
|
|
AKSS-Enzym |
* |
|
|
|
|
|
|
AKSS-NaCl |
* |
|
|
|
|
|
|
AK-Titration n.Diff. |
* |
|
|
|
|
|
|
AK-Titration(1Reihe) |
* |
|
|
|
|
|
|
Albumin i.Serum |
* |
|
|
|
|
3500-5500 |
mg/dl |
Albumin i.Urin |
* |
|
|
|
|
0,1 - 3,7 |
mg/dl |
Albumin rel.(Serum-Epho) |
* |
0 |
M |
1 |
M |
53,0 - 61,0 |
% |
|
* |
2 |
M |
12 |
M |
53,0 - 61,0 |
% |
|
* |
13 |
M |
4 |
J |
53,4 - 64,8 |
% |
alkal. Phosphatase |
* |
0 |
T |
10 |
T |
68 - 275 |
U/l |
|
* |
11 |
T |
30 |
T |
86 – 354 |
U/l |
|
* |
1 |
M |
6 |
M |
74 – 440 |
U/l |
|
* |
7 |
M |
12 |
M |
74 – 427 |
U/l |
|
* |
13 |
M |
18 |
M |
68 – 397 |
U/l |
|
* |
19 |
M |
24 |
M |
68 – 360 |
U/l |
|
* |
2 |
J |
9 |
J |
68 – 306 |
U/l |
|
* |
10 |
J |
15 |
J |
80 – 427 |
U/l |
|
* |
16 |
J |
99 |
J |
27 – 127 |
U/l |
Alkohol im Serum |
* |
|
|
|
|
0-0.1 |
g/l |
alpha 1 Globulin rel. (Serum-Epho) |
* |
0 |
M |
11 |
M |
4 – 12 |
% |
|
* |
1 |
J |
3 |
J |
4 – 9 |
% |
|
* |
4 |
J |
6 |
J |
5 – 10 |
% |
|
* |
7 |
J |
9 |
J |
4 – 10 |
% |
|
* |
10 |
J |
12 |
J |
5 – 8 |
% |
|
* |
13 |
J |
14 |
J |
4 – 8 |
% |
|
* |
>15 |
J |
|
|
3 – 10 |
% |
alpha 2 Globulin rel. (Serum-Epho) |
* |
0 |
M |
11 |
M |
6 – 19 |
% |
|
* |
1 |
J |
3 |
J |
9 – 17 |
% |
|
* |
4 |
J |
6 |
J |
6 – 19 |
% |
|
* |
7 |
J |
9 |
J |
6 – 19 |
% |
|
* |
10 |
J |
12 |
J |
8 – 14 |
% |
|
* |
13 |
J |
14 |
J |
7 – 13 |
% |
|
* |
>15 |
J |
|
|
7 – 13 |
% |
AMA |
* |
|
|
|
|
Negativ (< 1:80) |
Titer |
Ammoniak |
* |
|
|
|
|
25 – 94 |
ug/dl |
Amphetamine s. Drogenscreening |
* |
|
|
|
|
|
|
Amylase i.Serum |
* |
|
|
|
|
0 - 100 |
U/l |
Amylase i.Urin |
* |
|
|
|
|
0 - 460 |
U/l |
ANA (quantitativ) |
* |
|
|
|
|
Negativ (<1:40) |
Titer |
ANCA |
* |
|
|
|
|
Negativ (<1:20) |
Titer |
anorg. Phosphat i.S. |
* |
|
|
>18 |
J |
2.5 - 4.8 |
mg/dl |
|
* |
0 |
T |
30 |
T |
3,9 - 7,7 |
mg/dl |
|
* |
1 |
M |
12 |
M |
3,5 - 6,6 |
mg/dl |
|
* |
1 |
J |
3 |
J |
3,1 - 6,0 |
mg/dl |
|
* |
4 |
J |
6 |
J |
3,3 - 5,6 |
mg/dl |
|
* |
7 |
J |
9 |
J |
3,0 - 5,4 |
mg/dl |
|
* |
10 |
J |
12 |
J |
3,2 - 5,7 |
mg/dl |
|
* |
13 |
J |
15 |
J |
2,9 - 5,1 |
mg/dl |
|
* |
16 |
J |
18 |
J |
2,7 - 4,9 |
mg/dl |
Anti-ds-DNA |
* |
|
|
|
|
Negativ (<1:10) |
Titer |
Anti-Faktor 10a |
* |
|
|
|
|
0-0.1 |
|
Antigen M |
* |
|
|
|
|
|
|
Antigen N |
* |
|
|
|
|
|
|
Antigen P1 |
* |
|
|
|
|
|
|
Antigen S |
* |
|
|
|
|
|
|
Anti-HBc (IgG) |
* |
|
|
|
|
|
|
Anti-HBc (IgM) |
* |
|
|
|
|
|
|
Anti-HBs qualitativ |
* |
|
|
|
|
|
|
Anti-HBs quantitativ (ohne Impfung) |
* |
|
|
|
|
0 – 10,0 |
mIE/ml |
Anti-HBs quantitativ (mit Impfung) |
* |
|
|
|
|
> 100 |
mIE/ml |
Antikoerpersuchtest |
* |
|
|
|
|
|
|
Antimitochondr. AK: siehe AMA |
* |
|
|
|
|
|
|
Antinucleaere AK: siehe ANA |
* |
|
|
|
|
|
|
Anti-Strept.O. quantitativ (AST) |
* |
|
|
|
|
0 -200 |
IU/ml |
Antithrombin 3 |
* |
0 |
M |
3 |
M |
42 - 80 |
% |
|
* |
> 4 |
M |
|
|
75 - 125 |
% |
APC-Sensitivität (s. Protein C global) |
|
|
|
|
|
|
|
Apolipoprotein A1 |
M |
|
|
|
|
106-148 |
mg/dl |
Apolipoprotein A2 |
W |
|
|
|
|
117-167 |
mg/dl |
Apolipoprotein B |
M |
|
|
|
|
59 -105 |
mg/dl |
|
W |
|
|
|
|
51-93 |
mg/dl |
ASL-Latex |
* |
|
|
|
|
Negativ |
|
ASMA |
* |
|
|
|
|
Negativ (<1:80) |
Titer |
Bakterien i.Urin |
* |
|
|
|
|
Negativ |
|
Barbiturate s. Drogenscreening |
|
|
|
|
|
|
|
Basenabweichung BE (art.) |
* |
|
|
|
|
- 2 bis + 3 |
mmol/l |
Basenabweichung BE (kap.) |
* |
|
|
|
|
- 2 bis + 3 |
mmol/l |
Basenabweichung BE (ven.) |
* |
|
|
|
|
- 2 bis + 3 |
mmol/l |
Basophile |
* |
|
|
|
|
0 – 1 |
% |
Batroxobinzeit (Reptilasezeit) |
* |
|
|
|
|
16 - 22 |
sec. |
<Bence-Jones-Prot. s. Kappa/Lambda |
* |
|
|
|
|
|
|
Benzodiazepine s. Drogenscreening |
* |
|
|
|
|
|
|
Beta-HCG (Serum) |
M, F |
|
|
|
|
0 - 5 |
mIU/ml |
|
Frauen postmenopausal |
|
|
|
|
<10 |
mIU/ml |
|
Schwangerschaft 3.-4. Woche |
|
|
|
|
9-130 |
mIU/ml |
|
Schwangerschaft 4.-5. Woche |
|
|
|
|
75-2600 |
mIU/ml |
|
Schwangerschaft 5.-6. Woche |
|
|
|
|
850-20800 |
mIU/ml |
|
Schwangerschaft 6.-7. Woche |
|
|
|
|
4000-100200 |
mIU/ml |
|
Schwangerschaft 7.-12. Woche |
|
|
|
|
11500-289000 |
mIU/ml |
|
Schwangerschaft 12.-16. Woche |
|
|
|
|
18300-137000 |
mIU/ml |
|
Schwangerschaft 16.-29. Woche |
|
|
|
|
1400-53000 |
mIU/ml |
|
Schwangerschaft 29.-41. Woche |
|
|
|
|
940-60000 |
mIU/ml |
Beta-HCG (Liquor) |
* |
|
|
|
|
< 6 |
% der Serumkonzentration |
Beta-Globulin rel. (Serum-Epho) |
* |
0 |
M |
11 |
M |
6 – 10 |
% |
|
* |
1 |
J |
3 |
J |
6 – 10 |
% |
|
* |
4 |
J |
6 |
J |
6 – 10 |
% |
|
* |
7 |
J |
9 |
J |
6 – 11 |
% |
|
* |
10 |
J |
12 |
J |
7 – 12 |
% |
|
* |
13 |
J |
14 |
J |
7 – 12 |
% |
|
* |
>15 |
J |
|
|
6 - 12 |
% |
BG-Merkm(Cw,K,Du,Fy) |
* |
|
|
|
|
|
|
BG-Merkm(Kidd,Luth.) |
* |
|
|
|
|
|
|
Bikarbonat (s. HCO3-) |
* |
|
|
|
|
|
|
Bilirubin |
* |
|
|
|
|
0.1 - 1.0 |
mg/dl |
Bilirubin i.Serum |
* |
|
|
|
|
0.1 - 1.0 |
mg/dl |
Bilirubin i.Urin |
* |
|
|
|
|
Negativ |
|
Blutbild |
* |
|
|
|
|
|
|
Leukocyten |
* |
|
|
|
|
4,0 - 10,0 |
/nl |
Erythrocyten |
M |
|
|
|
|
4.5 - 6.3 |
/pl |
|
W |
|
|
|
|
4,2 – 5,4 |
/pl |
Haematokrit |
* |
|
|
|
|
36 - 52 |
% |
|
M |
|
|
|
|
38 - 52 |
% |
|
W |
|
|
|
|
36 - 46 |
% |
Haemoglobin |
* |
|
|
|
|
12 - 18 |
g/dl |
|
M |
|
|
|
|
14 - 18 |
g/dl |
|
W |
|
|
|
|
12 - 16 |
g/dl |
MCH |
* |
|
|
|
|
26 - 32 |
Pg |
MCHC |
* |
|
|
|
|
32 - 36 |
g/dl |
MCV |
* |
|
|
|
|
77 - 95 |
Fl |
Thrombocyten |
* |
|
|
|
|
140-440 |
/nl |
Blut i.Urin |
* |
|
|
|
|
Negativ |
|
Blutgasanalyse |
* |
|
|
|
|
|
|
Basenabweichung BE (art.) |
* |
|
|
|
|
- 2 bis + 3 |
mmol/l |
Basenabweichung BE (kap.) |
* |
|
|
|
|
- 2 bis + 3 |
mmol/l |
Basenabweichung BE (ven.) |
* |
|
|
|
|
- 2 bis + 3 |
mmol/l |
HCO3- (art.) |
* |
|
|
|
|
22 – 26 |
mmol/l |
HCO3- (kap.) |
* |
|
|
|
|
22 – 27 |
mmol/l |
HCO3- (ven.) |
* |
|
|
|
|
23 - 27 |
mmol/l |
O2 -Sättigung (art.) |
* |
|
|
|
|
94 – 98 |
% |
O2 -Sättigung (kap.) |
* |
|
|
|
|
94 – 98 |
% |
O2-Sättigung (ven.) |
* |
|
|
|
|
54 - 69 |
% |
PO2 (art.) |
* |
|
|
|
|
71 – 104 |
mmHg |
PO2 (kap.) |
* |
|
|
|
|
71 – 104 |
mmHg |
PO2 (ven.) |
* |
|
|
|
|
35 - 40 |
mmHg |
PCO2 (art.) |
* |
|
|
|
|
35 - 46 |
mmHg |
PCO2 (kap.) |
* |
0 |
T |
9 |
T |
21 - 41 |
mmHg |
|
* |
10 |
T |
3 |
M |
28 – 40 |
mmHg |
|
* |
> 3 |
M |
|
|
32 – 43 |
mmHg |
PCO2 (ven.) |
* |
|
|
|
|
37 - 50 |
mmHg |
pH (art.) |
* |
0 |
T |
30 |
T |
7,09 – 7,61 |
|
|
* |
> 30 |
T |
|
|
7,35 – 7,45 |
|
pH (kap.) |
* |
0 |
T |
30 |
T |
7,09 – 7,61 |
|
|
* |
> 30 |
T |
|
|
7,35 – 7,45 |
|
pH (ven.) |
* |
0 |
T |
30 |
T |
7,09 – 7,61 |
|
PO2 (art.) |
* |
> 30 |
T |
|
|
7,35 – 7,45 |
mmHg |
PO2 (kap.) |
* |
|
|
|
|
|
mmHg |
PO2 (ven.) |
* |
|
|
|
|
|
mmHg |
Blutungszeit n. Ivy |
* |
|
|
|
|
0 - 9 |
min |
Blutzucker nüchtern (Serum) |
* |
|
|
|
|
60 - 105 |
mg/dl |
BSG 1h-Wert |
* |
|
|
|
|
3 - 10 |
mm |
BSG 2h-Wert |
* |
|
|
|
|
5 - 20 |
mm |
C3-Komplement |
* |
|
|
|
|
85 -193 |
mg/dl |
C4-Komplement |
* |
0 |
M |
3 |
|
7 – 30 |
mg/dl |
|
* |
3 |
M |
6 |
|
8 - 30 |
mg/dl |
|
* |
> 6 |
M |
|
|
12 – 36 |
mg/dl |
CA-125 |
* |
|
|
|
|
0 - 35 |
U/ml |
CA-15-3 |
* |
|
|
|
|
0 - 28 |
U/ml |
CA-19-9 |
* |
|
|
|
|
0 - 37 |
U/ml |
Calcium i.Urin |
* |
|
|
|
|
2,5-8,0 |
mmol/24h |
Calcium im Serum |
Frühgeb. |
|
|
|
|
1,23 – 2,55 |
mmol/l |
|
* |
1 |
T |
6 |
T |
1,96 - 2,66 |
mmol/l |
|
* |
7 |
T |
3 |
J |
2,19 – 2,51 |
mmol/l |
|
* |
4 |
J |
6 |
J |
2,19 – 2,51 |
mmol/l |
|
* |
7 |
J |
9 |
J |
2,19 – 2,51 |
mmol/l |
|
* |
10 |
J |
11 |
J |
2,22 – 2,51 |
mmol/l |
|
* |
12 |
J |
13 |
J |
2,19 – 2,64 |
mmol/l |
|
* |
14 |
J |
15 |
J |
2,29 – 2,66 |
mmol/l |
|
* |
16 |
J |
18 |
J |
2,22 – 2,66 |
mmol/l |
|
* |
> 18 |
J |
|
|
2,0 – 2,7 |
mmol/l |
Cannabinoide s. Drogenscreening |
|
|
|
|
|
|
|
CEA |
* |
|
|
|
|
0 – 5 |
ng/ml |
Chlamydia-AK (IgG,IgA) |
* |
|
|
|
|
|
|
Chlorid i.Serum |
* |
|
|
|
|
96 –108 |
mmol/l |
Chlorid i.Urin |
* |
|
|
|
|
100-200 |
mmol/24h |
Cholesterin |
* |
|
|
|
|
90 –200 |
mg/dl (empf. Richtwert) |
|
M |
<19 |
J |
|
|
120 – 197 |
mg/dl |
|
M |
19 |
J |
24 |
J |
128 – 213 |
mg/dl |
|
M |
25 |
J |
29 |
J |
139 – 240 |
mg/dl |
|
M |
30 |
J |
34 |
J |
147 – 267 |
mg/dl |
|
M |
35 |
J |
39 |
J |
147 – 274 |
mg/dl |
|
M |
40 |
J |
44 |
J |
151 – 282 |
mg/dl |
|
M |
45 |
J |
49 |
J |
155 – 290 |
mg/dl |
|
M |
50 |
J |
54 |
J |
159 – 290 |
mg/dl |
|
M |
>50 |
J |
|
|
162 – 294 |
mg/dl |
|
W |
<19 |
J |
|
|
128 – 213 |
mg/dl |
|
W |
19 |
J |
24 |
J |
128 – 228 |
mg/dl |
|
W |
25 |
J |
29 |
J |
128 – 240 |
mg/dl |
|
W |
30 |
J |
34 |
J |
135 – 240 |
mg/dl |
|
W |
35 |
J |
39 |
J |
151 - 271 |
mg/dl |
|
W |
40 |
J |
44 |
J |
155 - 278 |
mg/dl |
|
W |
50 |
J |
54 |
J |
151 – 286 |
mg/dl |
|
W |
>54 |
J |
|
|
174 – 309 |
mg/dl |
Cholinesterase |
* |
|
|
|
|
3,5 – 11,7 |
KU/l |
Chymotrypsin i.Stuhl |
* |
|
|
|
|
>3 |
U/g |
CK-MB |
* |
|
|
|
|
5 – 31 |
U/l |
CK-nac. |
* |
0 |
T |
3 |
T |
14 – 786 |
U/l |
|
* |
4 |
T |
10 |
T |
14 – 427 |
U/l |
|
* |
11 |
T |
31 |
T |
14 – 215 |
U/l |
|
* |
>1 |
M |
|
|
14 – 173 |
U/l |
CMV-AK (IgG,IgM) |
* |
|
|
|
|
|
|
CMV-AK (IgM) |
* |
|
|
|
|
|
|
CMV-AK(IgG )ABBOTT |
* |
|
|
|
|
0 - 15 |
AU/ml |
Cocain s. Drogenscreening |
|
|
|
|
|
|
|
Cortisol im Serum |
* |
|
|
|
|
2 – 20 |
ug/dl |
Cortisol. 20.00 Uhr |
* |
|
|
|
|
2 – 10 |
ug/dl |
Cortisol. 8.00 Uhr |
* |
|
|
|
|
6 - 20 |
ug/dl |
CRP |
* |
|
|
|
|
0.1 - 0.5 |
mg/dl |
CRP-Latex |
* |
|
|
|
|
Negativ |
|
Diff.Blutbild |
* |
|
|
|
|
|
|
Segmentkernige |
* |
|
|
|
|
50 - 75 |
% |
Lymphozyten |
* |
|
|
|
|
25 – 40 |
% |
Monozyten |
|
|
|
|
|
0 - 8 |
% |
Stabkernige |
* |
|
|
|
|
0 - 5 |
% |
Eosinophile |
* |
|
|
|
|
0 – 4 |
% |
Basophile |
* |
|
|
|
|
0 - 1 |
% |
Lymph. Reizformen |
* |
|
|
|
|
0 - 0 |
% |
Lymphoblasten |
* |
|
|
|
|
0 - 0 |
% |
Myeloblasten |
* |
|
|
|
|
0 - 0 |
% |
Myelocyten |
* |
|
|
|
|
0 - 0 |
% |
Plasmazellen |
* |
|
|
|
|
0 - 0 |
% |
Promyelocyten |
* |
|
|
|
|
0 - 0 |
% |
Digitoxin |
* |
|
|
|
|
10 - 25 |
ng/ml |
Digoxin |
* |
|
|
|
|
0.8-2.0 |
ng/ml |
D-Dimere |
* |
|
|
|
|
64 – 246 |
µg/l |
Dir. Coombs-Test |
* |
|
|
|
|
|
|
Direktes Bilirubin |
* |
|
|
|
|
bis 0.3 |
|
Drogenscreening im Urin |
* |
|
|
|
|
|
|
Amphetamine |
* |
|
|
|
|
Negativ |
|
Barbiturate |
* |
|
|
|
|
Negativ |
|
Benzodiazepine |
* |
|
|
|
|
Negativ |
|
Cannibinoide (THC) |
* |
|
|
|
|
Negativ |
|
Cocain und Metabolite |
* |
|
|
|
|
Negativ |
|
Methadon |
* |
|
|
|
|
Negativ |
|
Opiate |
* |
|
|
|
|
Negativ |
|
Phencyclidin und Metabolite |
* |
|
|
|
|
Negativ |
|
Trizyklische Antidepressiva |
* |
|
|
|
|
Negativ |
|
Eisen i.Serum |
M |
>14 |
J |
|
|
59 -150 |
µg/dl |
|
W |
>14 |
J |
|
|
37-145 |
µg/dl |
|
* |
0 |
M |
3 |
M |
78 – 140 |
µg/dl |
|
* |
4 |
M |
12 |
M |
50 – 101 |
µg/dl |
|
* |
13 |
M |
6 |
J |
78 – 151 |
µg/dl |
|
* |
7 |
J |
14 |
J |
89 – 179 |
µg/dl |
Eiweiß .i.Punktat |
* |
|
|
|
|
|
g/dl |
Eiweiß .i.U. quant. |
* |
|
|
|
|
0.02-0.15 |
g/l |
Eiweiß im Urin,Teststreifen |
* |
|
|
|
|
Negativ |
|
Elektrophorese i.U. |
* |
|
|
|
|
|
|
Elektrophorese im S. |
* |
|
|
|
|
|
|
Albumin rel. |
* |
0 |
T |
365 |
T |
53 – 61 |
% |
alpha 1 Globulin rel |
* |
0 |
T |
365 |
T |
4 – 12 |
% |
alpha 2 Globulin rel |
* |
0 |
T |
365 |
T |
6 – 19 |
% |
b-Globulin rel. |
* |
0 |
T |
365 |
T |
6 – 10 |
% |
gamma-Globulin rel. |
* |
0 |
T |
365 |
T |
2 – 14 |
% |
Albumin rel. |
* |
1 |
J |
3 |
J |
52 – 65 |
% |
alpha 1 Globulin rel |
* |
1 |
J |
3 |
J |
4 – 9 |
% |
alpha 2 Globulin rel |
* |
1 |
J |
3 |
J |
9 – 17 |
% |
b-Globulin rel. |
* |
1 |
J |
3 |
J |
6 – 10 |
% |
gamma-Globulin rel. |
* |
1 |
J |
3 |
J |
4 – 15 |
% |
Albumin rel. |
* |
4 |
J |
6 |
J |
53,4 – 64,8 |
% |
alpha 1 Globulin rel |
* |
4 |
J |
6 |
J |
5 – 10 |
% |
alpha 2 Globulin rel |
* |
4 |
J |
6 |
J |
6 – 19 |
% |
b-Globulin rel. |
* |
4 |
J |
6 |
J |
6 – 10 |
% |
gamma-Globulin rel. |
* |
4 |
J |
6 |
J |
8 – 17 |
% |
Albumin rel. |
* |
7 |
J |
9 |
J |
53,4 – 64,8 |
% |
alpha 1 Globulin rel |
* |
7 |
J |
9 |
J |
4 – 10 |
% |
alpha 2 Globulin rel |
* |
7 |
J |
9 |
J |
6 – 19 |
% |
b-Globulin rel. |
* |
7 |
J |
9 |
J |
6 – 11 |
% |
gamma-Globulin rel. |
* |
7 |
J |
9 |
J |
9 – 17 |
% |
Albumin rel. |
* |
10 |
J |
12 |
J |
53,4 – 64,8 |
% |
alpha 1 Globulin rel |
* |
10 |
J |
12 |
J |
5 – 8 |
% |
alpha 2 Globulin rel |
* |
10 |
J |
12 |
J |
8 – 14 |
% |
b-Globulin rel. |
* |
10 |
J |
12 |
J |
7 – 12 |
% |
gamma-Globulin rel. |
* |
10 |
J |
12 |
J |
8 – 19 |
% |
Albumin rel. |
* |
13 |
J |
14 |
J |
53,4 – 64,8 |
% |
alpha 1 Globulin rel |
* |
13 |
J |
14 |
J |
4 – 8 |
% |
alpha 2 Globulin rel |
* |
13 |
J |
14 |
J |
7 – 13 |
% |
b-Globulin rel. |
* |
13 |
J |
14 |
J |
7 – 12 |
% |
gamma-Globulin rel. |
* |
13 |
J |
14 |
J |
7 - 17 |
% |
Albumin rel. |
* |
> 14 |
J |
|
|
53,4 – 64,8 |
% |
alpha 1 Globulin rel |
* |
> 14 |
J |
|
|
3 – 10 |
% |
alpha 2 Globulin rel |
* |
> 14 |
J |
|
|
7 – 13 |
% |
b-Globulin rel. |
* |
> 14 |
J |
|
|
6 – 12 |
% |
gamma-Globulin rel. |
* |
> 14 |
J |
|
|
8 - 21 |
% |
ENA (AAK gegen SCL 70, RNP, Jo1, Sm, SSA, SSB) |
* |
|
|
|
|
jeweils negativ |
|
Eosinophile |
* |
|
|
|
|
0 – 4 |
% |
Erythrocyten |
M |
|
|
|
|
4.5-6.3 |
/pl |
|
W |
|
|
|
|
4.2-5.4 |
/pl |
Ethanol |
s. Alkohol |
|
|
|
|
|
|
Faktor II |
* |
0 |
T |
30 |
T |
26 – 70 |
% |
|
* |
> 1 |
M |
|
|
70 - 120 |
% |
Faktor V |
* |
0 |
T |
30 |
T |
34 - 108 |
% |
|
* |
> 1 |
M |
|
|
70 -140 |
% |
Faktor VII |
* |
0 |
T |
30 |
T |
28 – 104 |
% |
|
* |
> 1 |
M |
|
|
70 -130 |
% |
Faktor VIII |
* |
0 |
T |
30 |
T |
38 – 178 |
% |
|
* |
> 1 |
M |
|
|
70 - 150 |
% |
Faktor IX |
* |
0 |
T |
30 |
T |
15 - 91 |
% |
|
* |
> 1 |
M |
|
|
70 -120 |
% |
Faktor X |
* |
0 |
T |
30 |
T |
12 – 68 |
% |
|
* |
> 1 |
M |
|
|
70 -140 |
% |
Faktor XI |
* |
0 |
T |
30 |
T |
10 – 60 |
% |
|
* |
> 1 |
M |
|
|
70 -120 |
% |
Faktor XII |
* |
0 |
T |
30 |
T |
13 - 93 |
% |
|
* |
> 1 |
M |
|
|
70 -150 |
% |
Faktor XIII |
* |
0 |
T |
30 |
T |
27 – 131 |
% |
|
* |
> 1 |
M |
|
|
70 – 140 |
% |
Ferritin |
M |
|
|
|
|
29 -370 |
ng/ml |
|
F (<50 J.) |
|
|
|
|
30 - 150 |
ng/ml |
|
F (>50 J.) |
|
|
|
|
30 - 300 |
ng/ml |
|
* |
1 |
T |
15 |
T |
90 - 628 |
ng/ml |
|
* |
16 |
T |
31 |
T |
144 - 399 |
ng/ml |
|
* |
1 |
M |
2 |
M |
87 - 430 |
ng/ml |
|
* |
3 |
M |
4 |
M |
37 - 223 |
ng/ml |
|
* |
5 |
M |
14 |
J |
20 - 120 |
ng/ml |
Fibr. n. Clauss |
* |
|
|
|
|
180 - 350 |
mg/dl |
|
Schwangerchaft1. – 10. Woche |
|
|
|
|
180 - 350 |
mg/dl |
|
Schwangerchaft11. – 15. Woche |
|
|
|
|
260 – 500 |
mg/dl |
|
Schwangerchaft> 16. Woche |
|
|
|
|
290 - 615 |
mg/dl |
Fibr.Spaltprodukte |
M |
|
|
|
|
0-5 |
µg/ml |
Fibrinmonomere |
* |
|
|
|
|
0-20 |
µg/ml |
Fibrinogen (s.o.) |
* |
|
|
|
|
180-350 |
mg/dl |
Freies Hämoglobin 1 |
* |
|
|
|
|
0 – 0,01 |
g/dl |
Freies PSA |
* |
|
|
|
|
0.1-0.934 |
ng/ml |
Freies T4 |
* |
|
|
|
|
0.8-2.0 |
ng/dl |
Gamma-Globulin s. Elektrophorese |
* |
|
|
|
|
|
|
?GT |
Neugeborene |
|
|
|
|
7 – 208 |
U/l |
|
* |
1 |
M |
3 |
M |
7 – 131 |
U/l |
|
* |
4 |
M |
12 |
M |
7 – 72 |
U/l |
|
* |
1 |
J |
14 |
J |
7 – 26 |
U/l |
|
* |
> 14 |
J |
|
|
7 – 38 |
U/l |
|
M |
> 18 |
J |
|
|
11 – 57 |
U/l |
|
W |
> 18 |
J |
|
|
7 - 36 |
U/l |
Gentamycin nach Gabe |
* |
|
|
|
|
5 - 10 |
mg/l |
Gentamycin vor Gabe |
* |
|
|
|
|
0,1 - 2,0 |
mg/l |
Gesamteiweiss i.Liquor |
* |
0 |
T |
30 |
T |
20 – 100 |
mg/dl |
|
* |
> 30 |
T |
|
|
15 – 45 |
mg/dl |
Gesamteiweiss i.Serum |
* |
|
|
|
|
6.5-8.5 |
g/dl |
GLDH |
* |
|
|
|
|
0.1-4.0 |
U/l |
|
Neugeborene |
|
|
|
|
0 - 9 |
U/l |
|
* |
31 |
T |
11 |
M |
0 - 7 |
U/l |
|
* |
1 |
J |
17 |
J |
0 – 4 |
U/l |
|
* |
> 18 |
J |
|
|
0 – 5 |
U/l |
Glucose i.Haemolysat |
* |
|
|
|
|
75 –110 |
mg/dl |
Glucose i.Liquor |
* |
|
|
|
|
40 – 80 |
mg/dl |
Glucose i.Punktat |
* |
|
|
|
|
60 – 95 |
mg/dl |
Glucose i.Serum |
* |
|
|
|
|
60 –105 |
mg/dl |
Glucose i.Urin |
* |
|
|
|
|
< 16 |
mg/dl |
Glucose qual.im Urin |
* |
|
|
|
|
Negativ |
|
GOT |
M |
> 16 |
J |
|
|
6 – 45 |
U/l |
|
W |
> 16 |
J |
|
|
6 – 38 |
U/l |
|
* |
0 |
T |
30 |
T |
15 – 94 |
U/l |
|
* |
31 |
T |
11 |
M |
18 – 67 |
U/l |
|
* |
1 |
J |
16 |
J |
13 – 55 |
U/l |
GPT |
M |
> 16 |
J |
|
|
6 – 55 |
U/l |
|
W |
> 16 |
J |
|
|
6 – 43 |
U/l |
|
* |
0 |
T |
30 |
T |
8 – 64 |
U/l |
|
* |
31 |
T |
11 |
M |
12 – 72 |
U/l |
|
* |
1 |
J |
16 |
J |
10 – 42 |
U/l |
Hämatokrit s. Blutbild |
|
|
|
|
|
|
|
Hämoglobin s. Blutbild |
|
|
|
|
|
|
|
Hämoglobin A1c |
* |
|
|
|
|
4.7-6.4 |
% |
HAM-TEST |
* |
|
|
|
|
|
|
Haptoglobin |
* |
|
|
|
|
13 -163 |
mg/dl |
Harnsaeure i. Punktat |
* |
|
|
|
|
3 - 7 |
mg/dl |
Harnsaeure i.Serum |
M |
> 15 |
J |
|
|
3.4-7.0 |
mg/dl |
|
W |
> 15 |
J |
|
|
2.4-5.7 |
mg/dl |
|
* |
1 |
J |
15 |
J |
2,5 – 5,7 |
mg/dl |
Harnsaeure i.Urin |
* |
|
|
|
|
0,3-1,1 |
g/24h |
Harnsteinanalyse |
* |
|
|
|
|
|
|
Harnstoff i.Serum |
M |
|
|
|
|
20 - 50 |
mg/dl |
|
W |
|
|
|
|
10 - 40 |
mg/dl |
Harnstoff i.Urin |
* |
|
|
|
|
1500-2600 |
mg/dl |
Harnstoff-Clearance |
* |
|
|
|
|
36 - 200 |
ml/min |
HAVAB IgG |
* |
|
|
|
|
|
|
HAV-AK (IgG) |
* |
|
|
|
|
|
|
HAV-AK (IgM) |
* |
|
|
|
|
|
|
HBA1c |
* |
|
|
|
|
4.7-6.4 |
% |
HBDH |
* |
|
|
|
|
65 - 184 |
U/l |
HBs Antigen Abbott |
* |
|
|
|
|
|
|
HBs-Antigen Behring |
* |
|
|
|
|
|
|
HCO3- s. Blutgase |
|
|
|
|
|
|
|
HCV-AK ABBOTT |
* |
|
|
|
|
|
|
HDL-Cholesterin |
* |
|
|
|
|
> 35 |
mg/dl |
|
M |
<19 |
J |
|
|
31 – 58 |
mg/dl |
|
M |
20 |
J |
24 |
J |
27 – 70 |
mg/dl |
|
M |
25 |
J |
39 |
J |
27 – 66 |
mg/dl |
|
M |
40 |
J |
44 |
J |
27 – 62 |
mg/dl |
|
M |
45 |
J |
49 |
J |
27 – 66 |
mg/dl |
|
M |
50 |
J |
54 |
J |
27 – 62 |
mg/dl |
|
M |
>54 |
J |
|
|
27 – 66 |
mg/dl |
|
W |
<19 |
J |
|
|
31 – 66 |
mg/dl |
|
W |
20 |
J |
24 |
J |
35 – 70 |
mg/dl |
|
W |
25 |
J |
29 |
J |
35 – 77 |
mg/dl |
|
W |
30 |
J |
34 |
J |
31 – 73 |
mg/dl |
|
W |
35 |
J |
39 |
J |
31 – 81 |
mg/dl |
|
W |
40 |
J |
44 |
J |
31 – 77 |
mg/dl |
|
W |
45 |
J |
49 |
J |
31 – 73 |
mg/dl |
|
W |
50 |
J |
54 |
J |
39 – 81 |
mg/dl |
|
W |
>54 |
J |
|
|
34 – 85 |
mg/dl |
Hemmstoff-Nachweis |
* |
|
|
|
|
Negativ |
|
HIV I/II-AK |
* |
|
|
|
|
|
|
IgA i.Serum |
* |
|
|
|
|
93 -445 |
mg/dl |
IgA i.Urin |
* |
|
|
|
|
0 - 1,1 |
mg/dl |
IgE i.Serum |
* |
0 |
T |
5 |
M |
0 - 20 |
kU/l |
|
* |
6 |
M |
11 |
M |
0 – 40 |
kU/l |
|
* |
> 1 |
J |
|
|
10 – 100 |
kU/l |
IgG i.Serum |
* |
|
|
|
|
802-1762 |
mg/dl |
IgG i.Urin |
* |
|
|
|
|
0 - 0,9 |
mg/dl |
IgM i.Serum |
* |
|
|
|
|
65 -280 |
mg/dl |
IgM i.Urin |
* |
|
|
|
|
0 - 0,7 |
mg/dl |
INR |
* |
|
|
|
|
0,85 – 1,15 |
|
Kaelteagglutinine |
* |
|
|
|
|
|
|
Kalium i.Serum |
* |
|
|
|
|
3.6-5.4 |
mmol/l |
Kalium i.Urin (Ausscheidung) |
* |
|
|
|
|
34 -126 |
mmol/24h |
Kappa L-Ketten i.S. |
* |
|
|
|
|
598-1329 |
mg/dl |
Kappa L-Ketten i.U. |
* |
|
|
|
|
0 - 1,8 |
mg/dl |
Katalase-Reaktion |
* |
|
|
|
|
|
|
Keton,qualitativ im Urin |
* |
|
|
|
|
Negativ |
|
Kreatinin i.Serum |
* |
0 |
T |
5 |
J |
0,3 – 0,7 |
mg/dl |
|
* |
6 |
J |
11 |
J |
0,5 – 0,9 |
mg/dl |
|
M |
12 |
J |
17 |
J |
0,7 – 1,1 |
mg/dl |
|
M |
18 |
J |
50 |
J |
0,7 – 1,2 |
mg/dl |
|
M |
> 50 |
J |
|
|
0,7 – 1,4 |
mg/dl |
|
W |
12 |
J |
17 |
J |
0,5 – 0,9 |
mg/dl |
|
W |
> 18 |
J |
|
|
0,7 – 1,1 |
mg/dl |
Kreatinin i.Urin |
* |
|
|
|
|
36-130 |
mg/dl |
Kreatinin-Clearance |
* |
|
|
|
|
95 -160 |
ml/min |
Kryoglobuline |
* |
|
|
|
|
negativ |
|
Kryoglobulin-Eiweiss |
|
|
|
|
|
|
|
Kryoglobulin-IFE |
|
|
|
|
|
|
|
Kryoglobulin-IgA |
|
|
|
|
|
|
|
Kryoglobulin-IgG |
|
|
|
|
|
|
|
Kryoglobulin-IgM |
|
|
|
|
|
|
|
Laktat i.Plasma |
* |
|
|
|
|
0.6-2.4 |
mmol/l |
Lambda L-Ketten i.S. |
* |
|
|
|
|
280-665 |
mg/dl |
Lambda L-Ketten i.U. |
* |
|
|
|
|
0 - 5,0 |
mg/dl |
Lamblien |
* |
|
|
|
|
Negativ |
|
LDH i.Punktat |
* |
|
|
|
|
10 -200 |
U/l |
LDH i.Serum |
M |
1 |
T |
30 |
T |
139-784 |
U/l |
|
M |
31 |
T |
365 |
T |
186-483 |
U/l |
|
M |
1 |
J |
3 |
J |
170-371 |
U/l |
|
M |
4 |
J |
6 |
J |
170-371 |
U/l |
|
M |
7 |
J |
9 |
J |
160-324 |
U/l |
|
M |
10 |
J |
12 |
J |
133-350 |
U/l |
|
M |
13 |
J |
15 |
J |
132-313 |
U/l |
|
M |
16 |
J |
18 |
J |
117-255 |
U/l |
|
M |
19 |
J |
99 |
J |
133-260 |
U/l |
|
W |
1 |
T |
30 |
T |
160-816 |
U/l |
|
W |
31 |
T |
365 |
T |
207-450 |
U/l |
|
W |
1 |
J |
3 |
J |
181-424 |
U/l |
|
W |
4 |
J |
6 |
J |
149-371 |
U/l |
|
W |
7 |
J |
9 |
J |
154-302 |
U/l |
|
W |
10 |
J |
12 |
J |
133-281 |
U/l |
|
W |
13 |
J |
15 |
J |
112-297 |
U/l |
|
W |
16 |
J |
18 |
J |
117-2500 |
U/l |
|
W |
19 |
J |
99 |
J |
133-260 |
U/l |
LDL-Cholesterin |
* |
|
|
|
|
10 –150 |
mg/dl (empf. Richtwert) |
|
M |
<19 |
J |
|
|
62 – 139 |
mg/dl |
|
M |
20 |
J |
24 |
J |
70 – 151 |
mg/dl |
|
M |
25 |
J |
29 |
J |
73 – 174 |
mg/dl |
|
M |
30 |
J |
34 |
J |
81 – 182 |
mg/dl |
|
M |
35 |
J |
39 |
J |
85 – 193 |
mg/dl |
|
M |
40 |
J |
44 |
J |
85 – 201 |
mg/dl |
|
M |
45 |
J |
49 |
J |
89 – 201 |
mg/dl |
|
M |
50 |
J |
54 |
J |
89 – 205 |
mg/dl |
|
M |
>54 |
J |
|
|
89 – 216 |
mg/dl |
|
W |
<19 |
J |
|
|
66 – 139 |
- |
|
W |
20 |
J |
24 |
J |
66 – 147 |
mg/dl |
|
W |
25 |
J |
29 |
J |
70 – 162 |
mg/dl |
|
W |
30 |
J |
34 |
J |
73 – 162 |
mg/dl |
|
W |
35 |
J |
39 |
J |
77 – 185 |
mg/dl |
|
W |
40 |
J |
44 |
J |
81 – 189 |
mg/dl |
|
W |
45 |
J |
49 |
J |
85 – 209 |
mg/dl |
|
W |
50 |
J |
54 |
J |
104 – 236 |
mg/dl |
|
W |
>54 |
J |
|
|
101 – 213 |
mg/dl |
Leukocyten s. Blutbild |
|
|
|
|
|
|
|
Leukozyten i.Urin |
* |
|
|
|
|
Negativ |
|
Lipase |
* |
|
|
|
|
7 – 60 |
U/l |
Lithium i.Serum |
* |
|
|
|
|
0.3 - 1,3 |
mmol/l |
LKM-Antikörper |
* |
|
|
|
|
Negativ |
|
Lymph. Reizformen s. Blutbild |
* |
|
|
|
|
|
|
Lymphoblasten s. Blutbild |
* |
|
|
|
|
|
|
Lymphocyten s. Blutbild |
* |
|
|
|
|
|
|
Magnesium i.Serum |
* |
|
|
|
|
0.8-1.3 |
mmol/l |
MCH s. Blutbild |
* |
|
|
|
|
|
|
MCHC s. Blutbild |
* |
|
|
|
|
|
|
MCV s. Blutbild |
* |
|
|
|
|
|
|
Methadon s. Drogenscreening |
|
|
|
|
|
|
|
Monocyten s. Blutbild |
* |
|
|
|
|
|
|
Mononucleose Test |
* |
|
|
|
|
Negativ |
|
Myeloblasten s. Blutbild |
* |
|
|
|
|
|
|
Myelocyten s. Blutbild |
* |
|
|
|
|
|
|
Myoglobin i.Serum |
* |
|
|
|
|
0 – 85 |
ug/l |
Myoglobin i.Urin |
* |
|
|
|
|
0 – 0 |
ug/l |
Natrium i.Serum |
* |
|
|
|
|
130 - 145 |
mmol/l |
Natrium i.Urin |
* |
|
|
|
|
130-250 |
mmol/24h |
Netilmycin nach Gabe |
* |
|
|
|
|
5 - 12 |
mg/l |
Netilmycin vor Gabe |
* |
|
|
|
|
0,1 - 3 |
mg/l |
Nitrit im Urin |
* |
|
|
|
|
Negativ |
|
Opiate s. Drogenscreening |
|
|
|
|
|
|
|
Osmolalität i.Serum |
* |
|
|
|
|
280 - 310 |
mosmol/kg |
Osmolalität i.Urin 4 |
* |
|
|
|
|
50-1200 |
mosmol/kg |
Osmot.Ery.Resistenz, Lysebeginn |
* |
|
|
|
|
0,45 – 0,48 |
%NaCl |
Osmot.Ery.Resistenz, Lyseende |
* |
|
|
|
|
0,28 – 0,33 |
%NaCl |
Oxidase Reaktion |
* |
|
|
|
|
|
|
Pandy-Reaktion |
* |
|
|
|
|
Negativ |
|
pCO2 s. Blutgase |
* |
|
|
|
|
|
mm Hg |
Phencyclidin (s. Drogenscreening) |
|
|
|
|
|
|
|
Phosphat i. Serum (s. anorganisches Phosphat) |
* |
|
|
|
|
|
|
Phosphat i.Urin |
* |
|
|
|
|
22 – 74 |
mg/dl |
Phosphat-Clearance |
* |
|
|
|
|
5,4 - 16,2 |
ml/min |
pH-Wert s. Blutgase |
* |
|
|
|
|
|
|
pH-Wert im Urin |
* |
|
|
|
|
4,5-8,0 |
|
Plasmazellen s. Blutbild |
* |
|
|
|
|
|
|
PO2-Wert s. Blutgase |
* |
|
|
|
|
|
|
Promyelocyten s. Blutbild |
* |
|
|
|
|
|
|
Prostata-Phosphatase |
M |
|
|
|
|
0,1 – 2,6 |
U/l |
|
W |
|
|
|
|
Negativ |
U/l |
Protein C s. Protein-C global |
|
|
|
|
|
|
|
Protein S s. Protein-C global |
* |
|
|
|
|
|
|
Protein-C global |
* |
|
|
|
|
0,8-1,8 |
Ratio |
PSA |
M |
|
|
|
|
0,1 – 5 |
ng/ml |
PTT |
* |
|
|
|
|
26 – 36 |
sec. |
QUICK |
* |
|
|
|
|
70 –130 |
% |
Reptilasezeit |
* |
|
|
|
|
16 - 22 |
sec |
Retikulocyten |
* |
|
|
|
|
5 – 15 |
o/oo |
Rheumafaktor |
* |
|
|
|
|
0 – 40 |
E/ml |
Ristocetin-Cofaktor (v. Willebrand-Faktor) |
* |
|
|
|
|
50 –150 |
% |
Sauerstoffsättigung (s. Blutgase) |
* |
|
|
|
|
|
|
Saure Phosphatase |
M |
|
|
|
|
0,6-5,8 |
U/l |
|
W |
|
|
|
|
0,6-4,9 |
U/l |
Sediment d. Punktats |
* |
|
|
|
|
|
|
Segmentkernige s. Blutbild |
* |
|
|
|
|
|
|
Serumelektrophorese s. Elektrophorese |
* |
|
|
|
|
|
|
Spezif. Gewicht im Urin |
* |
|
|
|
|
1,005-1,030 |
|
Stabkernige s. Blutbild |
* |
|
|
|
|
|
|
Strep.B-Serologie |
* |
|
|
|
|
|
|
Strep.D-Serologie |
* |
|
|
|
|
|
|
T3 |
* |
|
|
|
|
0.8-2.0 |
ng/ml |
T4 |
* |
|
|
|
|
4,5-12,0 |
µg/dl |
THC s. Drogenscreening im Urin |
* |
|
|
|
|
|
|
Theophyllin |
* |
|
|
|
|
10 – 20 |
mg/l |
|
Frühgeborene |
|
|
|
|
6 – 11 |
mg/l |
Thrombinzeit |
* |
|
|
|
|
14 – 21 |
sec. |
Thrombozyten s. Blutbild |
* |
|
|
|
|
140-440 |
/nl |
Thrombozytenfunktion (Kollagen/Epinephrin) |
* |
|
|
|
|
85 - 165 |
sec |
Thrombozytenfunktion (Kollagen/ADP) |
* |
|
|
|
|
71 - 118 |
sec |
TPHA |
* |
|
|
|
|
Negativ |
|
Transferrin |
* |
|
|
|
|
202-400 |
mg/dl |
Trichomonaden |
* |
|
|
|
|
Negativ |
|
Triglyceride |
* |
|
|
|
|
30 –200 |
mg/dl (empf. Richtwert) |
Triglyceride |
M |
<19 |
J |
|
|
40 – 140 |
mg/dl |
|
M |
20 |
J |
24 |
J |
41 – 206 |
mg/dl |
|
M |
25 |
J |
29 |
J |
46 – 274 |
mg/dl |
|
M |
30 |
J |
34 |
J |
48 – 309 |
mg/dl |
|
M |
35 |
J |
39 |
J |
55 – 317 |
mg/dl |
|
M |
40 |
J |
44 |
J |
54 – 363 |
mg/dl |
|
M |
45 |
J |
49 |
J |
55 – 412 |
mg/dl |
|
M |
50 |
J |
54 |
J |
56 – 352 |
mg/dl |
|
M |
>54 |
J |
|
|
54 – 344 |
mg/dl |
|
W |
<19 |
J |
|
|
39 – 150 |
mg/dl |
|
W |
20 |
J |
24 |
J |
40 – 153 |
mg/dl |
|
W |
25 |
J |
29 |
J |
35 – 159 |
mg/dl |
|
W |
30 |
J |
34 |
J |
41 – 186 |
mg/dl |
|
W |
35 |
J |
39 |
J |
41 – 203 |
mg/dl |
|
W |
40 |
J |
44 |
J |
41 – 207 |
mg/dl |
|
W |
45 |
J |
49 |
J |
45 – 213 |
mg/dl |
|
W |
50 |
J |
54 |
J |
51 – 200 |
mg/dl |
|
W |
>54 |
J |
|
|
43 – 256 |
mg/dl |
Trizyklische Antidepressiva s. Drogenscreening |
|
|
|
|
|
|
|
Troponin I |
* |
|
|
|
|
0 – 0,4 |
ng/ml |
TSH basal |
* |
0 |
T |
30 |
T |
0,25 – 19,00 |
mIU/l |
|
* |
> 30 |
T |
|
|
0,25 – 3,10 |
mIU/l |
TSH stimuliert |
* |
|
|
|
|
2,00 – 25,00 |
mIU/l |
U-Erythrocyten |
* |
|
|
|
|
0 – 2 |
/Gesichtsfeld |
U-Leukocyten |
* |
|
|
|
|
0 – 3 |
/Gesichtsfeld |
Uricult (Bakt.) |
* |
|
|
|
|
Negativ |
|
Urobilinogen i.Urin |
* |
|
|
|
|
< 1.0 |
mg/dl |
Wurmeier i.Stuhl |
* |
|
|
|
|
Negativ |
|
Zaehlkammer, U-Erythrocyten |
* |
|
|
|
|
< 9/3 |
/3 pro µl |
Zaehlkammer, U-Leukocyten |
* |
|
|
|
|
< 30/3 |
/3 pro µl |
Zellzahl i.Liquor |
* |
|
|
|
|
0 – 16 |
/3 pro µl |
Ziehl-Neelsen-F. |
* |
|
|
|
|
Negativ |
|